Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - triamcinolone acetonide - nasal spray, suspension - 55 microgram(s) - corticosteroids; triamcinolone

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - triamcinolone acetonide - nasal spray, suspension - 55 microgram(s)/dose - corticosteroids; triamcinolone

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

beijing tong ren tang australia pty ltd - curcuma longa, quantity: 27.65 mg (equivalent: curcuma longa, qty 27.65 mg); citrus aurantium, quantity: 36.87 mg (equivalent: citrus aurantium, qty 36.87 mg; equivalent: oxedrine, qty 0.41 mg); angelica polymorpha, quantity: 36.87 mg (equivalent: angelica polymorpha, qty 36.87 mg); boswellia carterii, quantity: 55.3 mg (equivalent: boswellia carterii, qty 55.3 mg); paeonia lactiflora, quantity: 55.3 mg (equivalent: paeonia lactiflora, qty 55.3 mg); achyranthes bidentata, quantity: 36.87 mg (equivalent: achyranthes bidentata, qty 36.87 mg); glycyrrhiza uralensis, quantity: 92.17 mg (equivalent: glycyrrhiza uralensis, qty 92.17 mg); paeonia suffruticosa, quantity: 36.87 mg (equivalent: paeonia suffruticosa, qty 36.87 mg); commiphora myrrha, quantity: 55.3 mg (equivalent: commiphora myrrha, qty 55.3 mg); carthamus tinctorius, quantity: 55.3 mg (equivalent: carthamus tinctorius, qty 55.3 mg); panax notoginseng, quantity: 73.73 mg (equivalent: panax notoginseng, qty 73.73 mg); corydalis turtschaninovii, quantity: 36.87 mg (equivalent: corydalis turtschaninovii, qty 36.87 mg); platycodon grandiflorus, quantity: 36.87 mg (equivalent: platycodon grandiflorus, qty 36.87 mg); saposhnikovia divaricata, quantity: 36.87 mg (equivalent: saposhnikovia divaricata, qty 36.87 mg); caesalpinia sappan, quantity: 55.3 mg (equivalent: caesalpinia sappan, qty 55.3 mg); clematis armandii, quantity: 36.87 mg (equivalent: clematis armandii, qty 36.87 mg); cucumis melo, quantity: 36.87 mg (equivalent: cucumis melo, qty 36.87 mg); dipsacus japonicus, quantity: 368.66 mg (equivalent: dipsacus japonicus, qty 368.66 mg); drynaria fortunei, quantity: 36.87 mg (equivalent: drynaria fortunei, qty 36.87 mg); paeonia veitchii, quantity: 73.73 mg (equivalent: paeonia veitchii, qty 73.73 mg); sparganium stoloniferum, quantity: 55.3 mg (equivalent: sparganium stoloniferum, qty 55.3 mg); daemonorops draco, quantity: 55.3 mg (equivalent: daemonorops draco, qty 55.3 mg); siphonestegia chinensis, quantity: 36.87 mg (equivalent: siphonestegia chinensis, qty 36.87 mg) - pill - excipient ingredients: honey - traditionally used in chinese medicine to eliminate/reduce/remove/resolve/dissipate blood-stasis ; traditionally used in chinese medicine to analgesic/anodyne/relieve pain ; traditionally used in chinese medicine to helps enhance/promote bone healing/repair ; traditionally used in chinese medicine to decrease/reduce/relieve symptoms of muscle injury/ailments ; traditionally used in chinese medicine to helps decrease/reduce/relieve symptoms of muscle sprain/strain ; traditionally used in chinese medicine to enhance/improve/promote healing of bruises ; traditionally used in chinese medicine to decrease/reduce/relieve bruise swelling

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

sandoz inc. - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 10 mg in 1 g - metronidazole gel usp, 1% is indicated for the topical treatment of inflammatory lesions of rosacea. metronidazole gel usp, 1% is contraindicated in patients with a history of  hypersensitivity to metronidazole or to any other ingredient in the formulation. risk summary available data have not established an association with metronidazole use during pregnancy and major birth defects, miscarriage or other adverse maternal or fetal outcomes. no fetotoxicity was observed after oral administration of metronidazole in pregnant rats or mice. the available data do not allow the calculation of relevant comparisons between the systemic exposures of metronidazole observed in animal studies to the systemic exposures that would be expected in humans after topical use of metronidazole gel usp, 1%. the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. risk summary it is not known whether metronidazole is present in human milk after topical administration. published literature reports the presence of metronidazole in human milk after oral administration. there are reports of diarrhea and candida infection in breastfed infants of mothers receiving oral treatment with metronidazole. there are no data on the effects of metronidazole on milk production. because of the potential for serious adverse reactions, advise patients that breastfeeding is not recommended during treatment with  metronidazole gel usp, 1%. safety and effectiveness in pediatric patients have not been established. sixty-six subjects aged 65 years and older were treated with metronidazole gel usp, 1% in the clinical study.   no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

lantheus medical imaging, inc. - gallium citrate ga-67 (unii: 4ljk511z86) (gallium cation ga-67 - unii:99t03j52w0) - gallium cation ga-67 2.0 mci in 1 ml - gallium citrate ga 67 injection may be useful in demonstrating the presence of the following malignancies: hodgkins disease, lymphomas and bronchogenic carcinoma. positive ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state. gallium citrate ga 67 injection may be useful as an aid in detecting some acute inflammatory lesions. none known.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

icu medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - intravenous solutions containing sodium chloride are indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient. none known. to open tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. some opacity of the plastic due to moisture absorption during the sterilization process may be observed. this is normal and does not affect the solution quality or safety. the opacity will diminish gradually. to add medication preparation for administration (use aseptic technique) warning: do not use flexible container in series connections.

Βέλγιο - Αγγλικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sanofi belgium sa-nv - triamcinolone acetonide 55 µg/dose - nasal spray, suspension - 55 µg/dose - triamcinolone acetonide 55 µg/dose - triamcinolone

Βέλγιο - Αγγλικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boehringer ingelheim animal health belgium sa-nv - fipronil 33,8 mg/0,5 ml; permethrin 252,4 mg/0,5 ml - spot-on solution - 67,6 mg/ml - 504,8 mg/ml - fipronil 67.6 mg/ml; permethrin 504.8 mg/ml - fipronil, combinations - dog

Βέλγιο - Αγγλικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boehringer ingelheim animal health belgium sa-nv - fipronil 67,6 mg/ml; permethrin 504,8 mg/ml - spot-on solution - 67,6 mg/ml - 504,8 mg/ml - fipronil 67.6 mg/ml; permethrin 504.8 mg/ml - fipronil, combinations - dog

Βέλγιο - Αγγλικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boehringer ingelheim animal health belgium sa-nv - permethrin 252,4 mg/0,5 ml; fipronil 33,8 mg/0,5 ml - spot-on solution - 67,6 mg/ml - 504,8 mg/ml - fipronil 67.6 mg/ml; permethrin 504.8 mg/ml - fipronil, combinations - dog